News

Yahoo24m
Eli Lilly weight loss pill shows promise in latest clinical trial
Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity ...
Eli Lilly to sell troubled N.J. pharmaceutical plant, but says jobs are safe. Here’s why.
Eli Lilly and Company has confirmed it’s selling its 25,000-square-foot manufacturing site in Branchburg. The decision was ...
BioSpace1h
Lilly’s Hotly Anticipated Oral Weight Loss Drug Delivers Lukewarm Results in Phase III
Lilly’s orforglipron cut body weight as expected in the Phase III ATTAIN-1 trial, but to a lesser extent than rival Novo ...
Fierce Biotech2h
Eli Lilly shakes up pain pipeline as part of quarterly R&D clearout
Lilly paid $47.5 million upfront to license the non-opioid pain drug candidate CNTX-0290 from Centrexion in 2019. The SSTR4 ...
Mounjaro appears more heart protective than Trulicity in trial of Eli Lilly diabetes drugs
Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...
The Daily Reporter16h
Eli Lilly and Co. could get $100 million in state tax credits
Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...
Jim Cramer Shows Concerns That Eli Lilly “Might Be a Little Diluted”
Eli Lilly and Company (NYSE: LLY) is one of the stocks in Jim Cramer’s game plan for this week. Cramer highlighted that his ...